FDA is on the lookout for the effects of personalized medicine on the orphan drug program and the potential for all diseases to be defined in such a way that they become eligible for orphan status.
As the therapeutic principles behind personalized medicine continue to develop, there may be more drugs targeted at smaller, more specific...